"Expanding knowledge and access to
emergency contraception in Europe"
"Expanding knowledge and access to emergency contraception in Europe"
These posts appear under the ‘Latest News’ heading.
(October 5, 2016) Gideon Richter released a new video that provides a very clear and easy-to-understand explanation of the mechanism of action of EC. This video, which incorporates 3-D animation, can be found here and is available for use in educational programas and trainings.
(October 5, 2016) The fall issue of the Journal of the University of Malta Medical School (Vol.28 Issue 3, 2016) focuses its editorial on emergency contraception. The article states that the most recent scientific evidence shows that LNG ECP delays ovulation and does not prevent implantation nor does ECP cause the loss of implanted embryos, and…
On May 2016, the European Medicines Agency (EMA) recommended the use of a non-hormonal emergency contraceptive (EC) when a woman in need of EC is using other interacting medicines (such as the HIV medicine efavirenz and ritonavir, certain medicines for tuberculosis and epilepsy, and herbal medicines containing St John’s wort). If using a cooper IUD…
A study published in March 2016 by researchers from the Department of International Health of Maastricht University, assesses the status of EC pills in European Union and associated countries a year after UPA was allowed for sale without prescription, and also looks into the impact of this switch on EC pills sales. Status of Emergency Contraceptives in Europe One Year…
In June 2016, the Maltese NGO Women’s Rights Foundation (WRF) filed a judicial protest on behalf of 102 women, requesting that emergency contraception is licensed, available, and accessible locally. The Minister of Health announced that the issue will be discussed at the Parliament Social Affairs committee in the coming months. Despite being a member of the European Union,…
As of June 2016, the mandatory dispensing protocol for UPA EC pills in Croatia has been cancelled. The dispensing protocol was developed by the Croatian Pharmacy Chamber, and its mandatory status was imposed by the Minister of Health in April 2015 following the European Medicine Agency’s (EMA) recommendation to sell UPA EC without a prescription….
On May 24, 2016, the United States Food and Drug Administration (FDA) announced completion of a review of the existing data related to the efficacy of EC and body weight, concluding that the data do not warrant a change to product labels: “The FDA has completed a review of available scientific data concerning the effectiveness of levonorgestrel (LNG)…
“Emergency contraception methods” (the EC wheel), a counselling tool for pharmacists and health providers published in May 2016 by ECEC, is now available in French, and can be used from tablets, cellphones and computers (on and off line). This tool is inspired in the WHO Medical eligibility criteria for contraceptive use (MEC) wheel, and based on the…
The UK organisation BPAS, launched a campaign that calls on pharmacies to reduce the cost of EC pills. As stated in ECEC´s last update on access to EC in Europe, the prices for both LNG and UPA EC pills when procured directly at the pharmacy in certain regions of the United Kingdom and in Ireland, are the higher in…
Emergency contraception In February 2016, the World Health Organisation published an updated version of its factsheet on emergency contraception. This update can be found on the WHO media center in English, French and Spanish.
Over the past year, there have been discussions around whether hormonal contraception should be resumed immediately after the intake of UPA EC. The concern is that using a progestin-containing contraceptive could counteract the effects of UPA EC. UPA is an anti-progestin that works by delaying or inhibiting ovulation; if a progestin-containing contraceptive is administered at the…
On July 2015, the French Ministry of Health (Haute Autorité de Santé) updated its guidance on emergency contraception, first published on December 2013. Fiche Mémo – Contraception d’urgence provides recommendations on LNG EC, UPA EC, and the use of Cu-IUD for EC, and can be accessed here.
Menú
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy
